Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Depreciation & Amortization (CF) (2009 - 2026)

Revvity's (RVTY) quarterly Depreciation & Amortization (CF) came in at $102.0 million in Q3 2026, down 0.72% on a YoY basis from $102.8 million in Q3 2025, and down 2.87% quarter-over-quarter from $105.1 million in Q2 2026.

Analysis

Revvity (RVTY) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

Revvity (RVTY) has reported Depreciation & Amortization (CF) for 18 consecutive years, with $102.0 million the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Depreciation & Amortization (CF) fell 0.72% year-over-year to $102.0 million; the trailing twelve-month figure through Jul 2026 stood at $412.2 million (changed 0.16% YoY), and the FY2025 full-year result was $405.3 million, down 5.26% from the prior year.
  • Depreciation & Amortization (CF) declined to $102.0 million in Q3 2026 per RVTY's latest filing, from $105.1 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $229.6 million in Q1 2023 and bottomed at $97.4 million in Q1 2025.
  • Historically, Depreciation & Amortization (CF) has averaged $113.2 million across 5 years, with a median of $106.5 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) jumped 55.77% in 2022, then tumbled 54.02% in 2023.
  • Over 5 years, Depreciation & Amortization (CF) stood at $109.3 million in 2022, then declined by 3.44% to $105.6 million in 2023, then dropped by 0.51% to $105.0 million in 2024, then fell by 1.86% to $103.1 million in 2025, then fell by 1.01% to $102.0 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $102.0 million, $105.1 million, and $103.1 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 66.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 102.04 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 24.14 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 19.06 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 9.66 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 58.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 102.04 Mn
Apr 5, 2026 105.06 Mn
Dec 28, 2025 103.08 Mn
Sep 28, 2025 102.06 Mn
Jun 29, 2025 102.78 Mn
Mar 30, 2025 97.42 Mn
Dec 29, 2024 105.03 Mn
Sep 29, 2024 107.67 Mn
Jun 30, 2024 107.34 Mn
Mar 31, 2024 107.80 Mn
Dec 31, 2023 105.57 Mn
Oct 1, 2023 108.26 Mn
Jul 2, 2023 108.93 Mn
Apr 2, 2023 109.01 Mn
Jan 1, 2023 229.61 Mn
Apr 3, 2022 109.33 Mn
Oct 3, 2021 51.56 Mn
Jul 4, 2021 75.64 Mn
Apr 4, 2021 70.19 Mn
Jan 3, 2021 19.13 Mn